Provided by Tiger Fintech (Singapore) Pte. Ltd.

Talaris Therapeutics Inc.

12.08
0.0000
Volume:- -
Turnover:837.55K
Market Cap:5.17M
PE:-0.67
High:12.08
Open:12.08
Low:12.08
Close:12.08
Loading ...
Aug 28, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Aug 26, 2023

Correspondence

Form CORRESP - Correspondence
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 06, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 22, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jun 22, 2023

Major Issues Report

Form 8-K - Current report
Jun 14, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 27, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 14, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 16, 2023

Major Issues Report

8-K - Current report